Phase 3CompletedINTERVENTIONAL
Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes
ClinicalTrials.gov · NCT01572740 · Registry updated: 2018-02-07
- Condition / research focus
- Diabetes; Diabetes Mellitus, Type 2
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- Japan
- Registry dates and results
- Start: 2012-04-05. Completion: 2013-03-27 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- liraglutide (drug)
- placebo (drug)
- insulin (drug)
Where the study takes place — 23 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Novo Nordisk Investigational Site
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Ebina-shi, Kanagawa, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Ebina-shi, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Kashiwara-shi, Osaka, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Katsushika-ku, Tokyo, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Koriyama-shi, Fukushima, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Miyazaki, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Naka-shi, Ibaraki, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Niigata-shi, Niigata, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Nishinomiya-shi, Hygo, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Okawa-shi, Fukuoka, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Osaka-shi, Osaka, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Ota-ku, Tokyo, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Oyama-shi, Tochigi, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Ōita, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Sapporo-shi, Hokkaido, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Sapporo-shi, Hokkaido, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Sendai, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Shimotsuke-shi, Tochigi, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Shizuoka, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Takatsuki-shi, Osaka, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported - Novo Nordisk Investigational Site
Yokohama, Japan
Site recruitment: Not reported